HIMS is a massive opportunity due to its integrated telehealth and manufacturing capabilities, poised to capitalize on the growing peptide market with a cheap valuation and strong growth.
Source Post
The creator discusses Hims & Hers Health (HIMS), highlighting its potential for significant growth due to t...
Mo InvestsMar 31, 2026
The creator discusses Hims & Hers Health (HIMS), highlighting its potential for significant growth due to the expanding peptide market and the company's integrated manufacturing and telehealth platform. They express strong conviction in HIMS, citing its current valuation, revenue growth, and strategic advantages.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
HIMS
buy opened Mar 31, 2026
+63.49%